933 related articles for article (PubMed ID: 33106049)
1. Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial.
Muramatsu T; Ozaki Y; Nanasato M; Ishikawa M; Nagasaka R; Ohota M; Hashimoto Y; Yoshiki Y; Takatsu H; Ito K; Kamiya H; Yoshida Y; Murohara T; Izawa H;
Circ Cardiovasc Interv; 2020 Nov; 13(11):e009314. PubMed ID: 33106049
[TBL] [Abstract][Full Text] [Related]
2. Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial): Results From the OPINION Imaging Study.
Otake H; Kubo T; Takahashi H; Shinke T; Okamura T; Hibi K; Nakazawa G; Morino Y; Shite J; Fusazaki T; Kozuma K; Ioji T; Kaneda H; Akasaka T;
JACC Cardiovasc Imaging; 2018 Jan; 11(1):111-123. PubMed ID: 28917678
[TBL] [Abstract][Full Text] [Related]
3. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
Kubo T; Shinke T; Okamura T; Hibi K; Nakazawa G; Morino Y; Shite J; Fusazaki T; Otake H; Kozuma K; Ioji T; Kaneda H; Serikawa T; Kataoka T; Okada H; Akasaka T;
Eur Heart J; 2017 Nov; 38(42):3139-3147. PubMed ID: 29121226
[TBL] [Abstract][Full Text] [Related]
4. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA; Maehara A; Généreux P; Shlofmitz RA; Fabbiocchi F; Nazif TM; Guagliumi G; Meraj PM; Alfonso F; Samady H; Akasaka T; Carlson EB; Leesar MA; Matsumura M; Ozan MO; Mintz GS; Ben-Yehuda O; Stone GW;
Lancet; 2016 Nov; 388(10060):2618-2628. PubMed ID: 27806900
[TBL] [Abstract][Full Text] [Related]
6. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ
Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909
[TBL] [Abstract][Full Text] [Related]
7. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
Waksman R; Piegari GN; Kabour A; Cannon L; Wang J; Adams G; Solankhi N; Smeglin A; Kereiakes DJ; Leiboff R; Spad MA; Torguson R; Chandra N; Bastian R; DeGroot J; Kayo MW; Stoll HP; Garcia-Garcia HM
Cardiovasc Revasc Med; 2017; 18(7):475-481. PubMed ID: 28923692
[TBL] [Abstract][Full Text] [Related]
8. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
9. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): Study protocol for a randomized controlled trial.
Kubo T; Shinke T; Okamura T; Hibi K; Nakazawa G; Morino Y; Shite J; Fusazaki T; Otake H; Kozuma K; Akasaka T
J Cardiol; 2016 Nov; 68(5):455-460. PubMed ID: 26763605
[TBL] [Abstract][Full Text] [Related]
10. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
11. OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON in patients with Acute Coronary Syndrome: Study protocol for a randomized controlled trial.
Otake H; Kubo T; Shinke T; Hibi K; Tanaka S; Ishida M; Kataoka T; Takaya T; Iwasaki M; Sonoda S; Ioji T; Akasaka T
J Cardiol; 2020 Sep; 76(3):317-321. PubMed ID: 32340781
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Trial Evaluating Online 3-Dimensional Optical Frequency Domain Imaging-Guided Percutaneous Coronary Intervention in Bifurcation Lesions.
Onuma Y; Kogame N; Sotomi Y; Miyazaki Y; Asano T; Takahashi K; Kawashima H; Ono M; Katagiri Y; Kyono H; Nakatani S; Muramatsu T; Sharif F; Ozaki Y; Serruys PW; Okamura T;
Circ Cardiovasc Interv; 2020 Dec; 13(12):e009183. PubMed ID: 33272034
[TBL] [Abstract][Full Text] [Related]
13. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
14. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
[TBL] [Abstract][Full Text] [Related]
15. Comparison of neointimal hyperplasia and peri-stent vascular remodeling after implantation of everolimus-eluting versus sirolimus-eluting stents: intravascular ultrasound results from the EXCELLENT study.
Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Gwon HC; Ahn T; Chae IH; Yoon JH; Kim HS; Jang Y;
Int J Cardiovasc Imaging; 2013 Aug; 29(6):1229-36. PubMed ID: 23456359
[TBL] [Abstract][Full Text] [Related]
16. Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial.
Costa JR; Chamié D; Abizaid AA; Ribeiro E; Meireles GC; Prudente M; Campos CA; Castro JP; Costa R; Lemos PA
Int J Cardiovasc Imaging; 2017 Feb; 33(2):161-168. PubMed ID: 27714601
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the relation between IVUS measurements and clinical outcome in elderly patients after sirolimus-eluting stent implantation for de novo coronary lesions.
Du R; Zhang RY; Zhang Q; Shi YH; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
Int J Cardiovasc Imaging; 2012 Oct; 28(7):1653-62. PubMed ID: 22222382
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
[TBL] [Abstract][Full Text] [Related]
19. Effect of Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial.
Hong SJ; Mintz GS; Ahn CM; Kim JS; Kim BK; Ko YG; Kang TS; Kang WC; Kim YH; Hur SH; Hong BK; Choi D; Kwon H; Jang Y; Hong MK;
JACC Cardiovasc Interv; 2020 Jan; 13(1):62-71. PubMed ID: 31918944
[TBL] [Abstract][Full Text] [Related]
20. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.
Jensen LO; Thayssen P; Maeng M; Ravkilde J; Krusell LR; Raungaard B; Junker A; Terkelsen CJ; Veien KT; Villadsen AB; Kaltoft A; Tilsted HH; Hansen KN; Aaroe J; Kristensen SD; Hansen HS; Jensen SE; Madsen M; Bøtker HE; Berencsi K; Lassen JF; Christiansen EH
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
